Pharmafile Logo

AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH

January 25, 2017 | mental health, patient advocacy 

Through sustained partnerships between advocacy and
industry, the US and Europe can overcome barriers to care.

As a source of human suffering, a barrier to workplace productivity, a burden on families and a driver of medical costs, mental illness amounts to an unparalleled public health crisis.Fortunately, there’s an abundance of smart thinking on how to improve the lives of people who struggle with major depression, schizophrenia, bipolar disorder, and other serious conditions. In this report, inVentiv Health has synthesized some of this analysis, with particular attention to there commendations, strategies, and aspirations of patient advocacy groups. We have also collected insights from pharmaceutical companies, payers, and other key stakeholders. Amidst great uncertainty in the healthcare environments of the US and Europe, inVentiv Health hopes to shine a light on unique challenges in mental health disorders and some possible solutions.

To download and read the full report please follow the link on the right side of this article.

This content was provided by Syneos Health®

Documents for download: